Are aromatase inhibitors effective in endometriosis treatment?

Bibliography

• Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-96
   PubMed Web of Science ®Google Scholar
• Ferrero S, Venturini PL, Ragni N, Pharmacological treatment of endometriosis: experience with aromatase inhibitors. Drugs 2009;69:943-52
   PubMed Web of Science ®Google Scholar
• Gupta S, Goldberg JM, Aziz N, Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril 2008;20:247-57
   Google Scholar
• Martin JD Jr, Hauck AE. Endometriosis in the male. Am Surg 1985;51:426-30
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Kado N, Ishihara H, Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002;83:149-55
   PubMed Web of Science ®Google Scholar
• Guo SW. Emerging drugs for endometriosis. Expert Opin Emerg Drugs 2008;13:547-71
   PubMed Web of Science ®Google Scholar
• Vercellini P, Pietropaolo G, De Giorgi O, Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril 2005;84:1375-87
   PubMed Web of Science ®Google Scholar
• Donnez J, Squifflet J, Pirard C, The efficacy of medical and surgical treatment of endometriosis-associated infertility: arguments in favour of a medico-surgical approach. Hum Reprod Update 2002;8:89-94
   PubMed Web of Science ®Google Scholar
• Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99
   PubMed Web of Science ®Google Scholar
• Mihalyi A, Simsa P, Mutinda KC, Emerging drugs in endometriosis. Expert Opin Emerg Drugs 2006;11:503-24
   PubMedGoogle Scholar
• Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009;15:441-61
   PubMed Web of Science ®Google Scholar
• Simpson ER, Mahendroo MS, Means GD, Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994;15:342-55
   PubMed Web of Science ®Google Scholar
• Simpson ER, Clyne C, Speed C, Tissue-specific estrogen biosynthesis and metabolism. Ann N Y Acad Sci 2001;949:58-67
   PubMed Web of Science ®Google Scholar
• Bulun SE, Lin Z, Imir G, Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005;57:359-83
   PubMed Web of Science ®Google Scholar
• Agarwal VR, Bulun SE, Leitch M, Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab 1996;81:3843-9
   PubMed Web of Science ®Google Scholar
• Harada N, Utsumi T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci U S A 1993;90:11312-16
   PubMed Web of Science ®Google Scholar
• Conley A, Hinshelwood M. Mammalian aromatases. Reproduction 2001;121:685-95
   PubMed Web of Science ®Google Scholar
• Delvoux B, Groothuis P, D'Hooghe T, Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 2009;94:876-83
   PubMed Web of Science ®Google Scholar
• Colette S, Lousse JC, Defrere S, Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod 2009;24:2133-41
   PubMed Web of Science ®Google Scholar
• Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174-9
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Noguchi T, Amatsu T, Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997;57:514-19
   PubMed Web of Science ®Google Scholar
• Noble LS, Takayama K, Zeitoun KM, Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997;82:600-6
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Kusuki I, Koshiba H, Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Gynecol Obstet Invest 1999;48 (Suppl 1):21-8
   PubMed Web of Science ®Google Scholar
• Zeitoun K, Takayama K, Michael MD, Bulun SE. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol 1999;13:239-53
   PubMed Web of Science ®Google Scholar
• Dheenadayalu K, Mak I, Gordts S, Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis. Fertil Steril 2002;78:825-9
   PubMed Web of Science ®Google Scholar
• Yang S, Fang Z, Suzuki T, Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased 0020 C/EBPbeta in endometriosis is associated with overexpression of aromatase. J Clin Endocrinol Metab 2002;87:2336-45
   PubMed Web of Science ®Google Scholar
• Ishihara H, Kitawaki J, Kado N, Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Lung Cancer 2003;79 (Suppl 1):735-42
   PubMedGoogle Scholar
• Brosens J, Verhoeven H, Campo R, High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome. Hum Reprod 2004;19:352-6
   PubMed Web of Science ®Google Scholar
• Wolfler MM, Nagele F, Kolbus A, A predictive model for endometriosis. Hum Reprod 2005;20:1702-8
   PubMed Web of Science ®Google Scholar
• Heilier JF, Donnez J, Defrere S, Serum dioxin-like compounds and aromatase (CYP19) expression in endometriotic tissues. Toxicol Lett 2006;167:238-44
   PubMed Web of Science ®Google Scholar
• Heilier JF, Donnez O, Van Kerckhove V, Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum. Fertil Steril 2006;85:1516-18
   PubMed Web of Science ®Google Scholar
• Matsuzaki S, Canis M, Pouly JL, Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Fertil Steril 2006;85:308-13
   PubMed Web of Science ®Google Scholar
• Murakami K, Nomura K, Shinohara K, Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism. Fertil Steril 2006;86:291-7
   PubMed Web of Science ®Google Scholar
• Dassen H, Punyadeera C, Kamps R, Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 2007;22:3148-58
   PubMed Web of Science ®Google Scholar
• Smuc T, Pucelj MR, Sinkovec J, Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol 2007;23:105-11
   PubMed Web of Science ®Google Scholar
• Bukulmez O, Hardy DB, Carr BR, Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 2008;149:1190-204
   PubMed Web of Science ®Google Scholar
• Bukulmez O, Hardy DB, Carr BR, Androstenedione up-regulation of endometrial aromatase expression via local conversion to estrogen: potential relevance to the pathogenesis of endometriosis. J Clin Endocrinol Metab 2008;93:3471-7
   PubMed Web of Science ®Google Scholar
• Izawa M, Harada T, Taniguchi F, An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells. Fertil Steril 2008;89:1390-6
   PubMed Web of Science ®Google Scholar
• Kyama CM, Overbergh L, Mihalyi A, Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril 2008;89:301-10
   PubMed Web of Science ®Google Scholar
• Toloubeydokhti T, Pan Q, Luo X, The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci 2008;15:993-1001
   PubMed Web of Science ®Google Scholar
• Aghajanova L, Hamilton A, Kwintkiewicz J, Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis. Biol Reprod 2009;80:105-14
   PubMed Web of Science ®Google Scholar
• Attar E, Tokunaga H, Imir G, Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab 2009;94:623-31
   PubMed Web of Science ®Google Scholar
• Morsch DM, Carneiro MM, Lecke SB, c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action. J Mol Histol 2009;40:53-8
   PubMed Web of Science ®Google Scholar
• Smuc T, Hevir N, Ribic-Pucelj M, Disturbed estrogen and progesterone action in ovarian endometriosis. Mol Cell Endocrinol 2009;301:59-64
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhao H, Xiang Q, Effect of Yikun Neiyi Wan on the expression of aromatase P450, COX-2, and ER related receptor in endometrial cells in vitro from patients with endometriosis. J Tradit Chin Med 2009;29:296-300
   PubMed Web of Science ®Google Scholar
• Hatok J, Zubor P, Galo S, Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis. Gynecol Endocrinol 2010; published online 17 June 2010, doi:10.3109/09513590.2010.491925
   PubMed Web of Science ®Google Scholar
• Izawa M, Taniguchi F, Uegaki T, Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril 2011;95:33-9
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Mita S, Takeuchi T, Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system. Steroids 2011;76:60-7
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Kusuki I, Koshiba H, Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999;72:1100-6
   PubMed Web of Science ®Google Scholar
• Velasco I, Rueda J, Acien P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod 2006;12:377-81
   PubMed Web of Science ®Google Scholar
• Acien P, Velasco I, Gutierrez M, Martinez-Beltran M. Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings. Fertil Steril 2007;88:32-8
   PubMed Web of Science ®Google Scholar
• Hudelist G, Czerwenka K, Keckstein J, Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod Sci 2007;14:798-805
   PubMed Web of Science ®Google Scholar
• Maia H Jr, Casoy J, Correia T, The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis. Gynecol Endocrinol 2008;24:123-8
   PubMed Web of Science ®Google Scholar
• Kim YA, Kim MR, Lee JH, Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis. Gynecol Obstet Invest 2009;68:73-81
   PubMed Web of Science ®Google Scholar
• Velasco I, Acien P, Campos A, Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression. J Reprod Immunol 2010;84:199-205
   PubMed Web of Science ®Google Scholar
• Holloway AC, Stys KA, Foster WG. DDE-induced changes in aromatase activity in endometrial stromal cells in culture. Endocrine 2005;27:45-50
   PubMed Web of Science ®Google Scholar
• Takemura Y, Osuga Y, Yoshino O, Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. J Clin Endocrinol Metab 2007;92:3213-18
   PubMed Web of Science ®Google Scholar
• Purohit A, Fusi L, Brosens J, Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy. Hum Reprod 2008;23:290-7
   PubMed Web of Science ®Google Scholar
• Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update 2006;12:49-56
   PubMed Web of Science ®Google Scholar
• Colette S, Lousse JC, Defrere S, Absence of aromatase expression in human peritoneal, ovarian and rectovaginal endometriotic lesions. Xth World Congress on Endometriosis; Melbourne, Australia; 2008
   Google Scholar
• Colette S, Donnez J. Endometriosis. N Engl J Med 2009;360:1911-12
   PubMed Web of Science ®Google Scholar
• Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-30
   PubMed Web of Science ®Google Scholar
• Absenger Y, Hess-Stumpp H, Kreft B, Cyr61, a deregulated gene in endometriosis. Mol Hum Reprod 2004;10:399-407
   PubMed Web of Science ®Google Scholar
• Konno R, Fujiwara H, Netsu S, Gene expression profiling of the rat endometriosis model. Am J Reprod Immunol 2007;58:330-43
   PubMed Web of Science ®Google Scholar
• Fabian CJ. The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. Int J Clin Pract 2007;61:2051-63
   PubMed Web of Science ®Google Scholar
• Howell A, Cuzick J, Baum M, Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2
   PubMed Web of Science ®Google Scholar
• Bonneterre J, Thurlimann B, Robertson JF, Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study. J Clin Oncol 2000;18:3748-57
   PubMed Web of Science ®Google Scholar
• Nabholtz JM, Buzdar A, Pollak M, Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol 2000;18:3758-67
   PubMed Web of Science ®Google Scholar
• Takayama K, Zeitoun K, Gunby RT, Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998;69:709-13
   PubMed Web of Science ®Google Scholar
• D'Hooghe TM, Kyama CM, Chai D, Nonhuman primate models for translational research in endometriosis. Reprod Sci 2009;16:152-61
   PubMed Web of Science ®Google Scholar
• Yano S, Ikegami Y, Nakao K. Studies on the effect of the new non-steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats. Arzneimittelforschung 1996;46:192-5
   PubMed Web of Science ®Google Scholar
• Altintas D, Kokcu A, Kandemir B, Comparison of the effects of raloxifene and anastrozole on experimental endometriosis. Eur J Obstet Gynecol Reprod Biol 2010;150:84-7
   PubMed Web of Science ®Google Scholar
• Ceyhan ST, Onguru O, Fidan U, Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model. Eur J Obstet Gynecol Reprod Biol 2010; published online 27 October 2010, doi:10.1016/j.ejogrb.2010.09.003
   PubMed Web of Science ®Google Scholar
• Oner G, Ozcelik B, Ozgun MT, The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model. Hum Reprod 2010;25:932-7
   PubMed Web of Science ®Google Scholar
• Fang Z, Yang S, Gurates B, Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab 2002;87:3460-6
   PubMed Web of Science ®Google Scholar
• Fechner S, Husen B, Thole H, Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. Fertil Steril 2007;88:1029-38
   PubMed Web of Science ®Google Scholar
• Bilotas M, Meresman G, Stella I, Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis. Fertil Steril 2010;93:2513-18
   PubMed Web of Science ®Google Scholar
• Erbayraktar S, Acar B, Saygili U, Management of intramedullary endometriosis of the conus medullaris. A case report. J Reprod Med 2002;47:955-8
   PubMed Web of Science ®Google Scholar
• Razzi S, Fava A, Sartini A, Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG 2004;111:182-4
   PubMed Web of Science ®Google Scholar
• Fatemi HM, Al-Turki HA, Papanikolaou EG, Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod Biomed Online 2005;11:455-7
   PubMed Web of Science ®Google Scholar
• Mousa NA, Bedaiwy MA, Casper RF. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol 2007;109:1421-3
   PubMed Web of Science ®Google Scholar
• Bohrer J, Chen CC, Falcone T. Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor. Fertil Steril 2008;90:2004.e7-9
   PubMedGoogle Scholar
• Sasson IE, Taylor HS. Aromatase inhibitor for treatment of a recurrent abdominal wall endometrioma in a postmenopausal woman. Fertil Steril 2009;92:1170.e1-4
   PubMed Web of Science ®Google Scholar
• Shippen ER, West WJ Jr. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril 2004;81:1395-8
   PubMed Web of Science ®Google Scholar
• Takai N, Ueda T, Nishida M, Bowel obstruction due to endometriosis in the rectovaginal septum. Clin Exp Obstet Gynecol 2008;35:295-6
   PubMed Web of Science ®Google Scholar
• Verma A, Konje JC. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients. Eur J Obstet Gynecol Reprod Biol 2009;143:112-15
   PubMed Web of Science ®Google Scholar
• Ferrero S, Biscaldi E, Luigi Venturini P, Remorgida V. Aromatase inhibitors in the treatment of bladder endometriosis. Gynecol Endocrinol 2010; published online 19 July 2010, doi:10.3109/09513590.2010.500425
   PubMed Web of Science ®Google Scholar
• Gurates B, Parmaksiz C, Kilic G, Treatment of symptomatic uterine leiomyoma with letrozole. Reprod Biomed Online 2008;17:569-74
   PubMed Web of Science ®Google Scholar
• Parsanezhad ME, Azmoon M, Alborzi S, A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 2010;93:192-8
   PubMed Web of Science ®Google Scholar
• Ailawadi RK, Jobanputra S, Kataria M, Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004;81:290-6
   PubMed Web of Science ®Google Scholar
• Remorgida V, Abbamonte HL, Ragni N, Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertil Steril 2007;88:724-6
   PubMed Web of Science ®Google Scholar
• Ferrero S, Camerini G, Seracchioli R, Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod 2009;24:3033-41
   PubMed Web of Science ®Google Scholar
• Ferrero S, Camerini G, Ragni N, Letrozole and norethisterone acetate in colorectal endometriosis. Eur J Obstet Gynecol Reprod Biol 2010;150:199-202
   PubMed Web of Science ®Google Scholar
• Evers JL, Dunselman GA, Groothuis P. Now you see them, now you don't. Fertil Steril 2005;84:31-2
   PubMed Web of Science ®Google Scholar
• Amsterdam LL, Gentry W, Jobanputra S, Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005;84:300-4
   PubMed Web of Science ®Google Scholar
• Remorgida V, Abbamonte LH, Ragni N, Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust NZ J Obstet Gynaecol 2007;47:222-5
   PubMed Web of Science ®Google Scholar
• Lossl K, Loft A, Freiesleben NL, Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study. Eur J Obstet Gynecol Reprod Biol 2009;144:48-53
   PubMed Web of Science ®Google Scholar
• Hefler LA, Grimm C, van Trotsenburg M, Nagele F. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil Steril 2005;84:1033-6
   PubMed Web of Science ®Google Scholar
• Soysal S, Soysal ME, Ozer S, The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004;19:160-7
   PubMed Web of Science ®Google Scholar
• Alborzi S, Hamedi B, Omidvar A, A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol Obstet 2010; published online 27 July 2010, doi:10.3109/09513590.2010.500425
   PubMed Web of Science ®Google Scholar
• Roghaei MA, Tehrany HG, Taherian A, Koleini N. Effects of Letrozole compared with Danazol on patients with confirmed endometriosis: a randomized clinical trial. IJFS 2010;4:67-72
   Web of Science ®Google Scholar
• Patwardhan S, Nawathe A, Yates D, Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008;115:818-22
   PubMed Web of Science ®Google Scholar